Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath tool

Atheroscler Suppl. 2020 Dec;42:e65-e71. doi: 10.1016/j.atherosclerosissup.2021.01.011.ABSTRACTPost-acute coronary syndrome (ACS) patients are at very high risk for recurrent events and mortality, despite the availability of effective pharmacological approaches. In 2018, the ACS EuroPath Survey, performed in collaboration with 555 European cardiologists, identified a sub-optimal LDL-C management in post-ACS patients. Based on these premises, the ACS EuroPath II project led to the development of a self-assessment tool to improve lipid management in these very high risk patients, taking into consideration the new 2019 ESC/EAS guidelines. This tool is built in 3 sections. The first is a questionnaire to assess the lipid management practice from the acute phase up to 12 months of follow-up. The main topics covered in this section relate to 1) acute phase (lipid management of ACS patients during hospitalization; 2) discharge (lipid management at discharge, with focus on follow-up plan); 3) follow-up (lipid management at the time of first and subsequent follow-ups); 4) referral pathway for definitive lipid management care of post-ACS patients; 5) evaluation of the achieved goal at 6 months to 1 year and key implications. The second section is a brief report to position the results against other European Union clinical practice and European guidelines. The last section allows the physician to evaluate and consider the implementation of one or more strategies, successfully developed i...

Source: Atherosclerosis Supplements - February 16, 2021 Category: Cardiology Authors: Alessandro Sionis Alberico L Catapano Gaetano M De Ferrari Dariusz Dudek J Wouter Jukema Ulf Landmesser Angela Pirillo Fran çois Schiele Azfar Zaman Jose L Zamorano Source Type: research